Register information Patent

DE file number : 60 2009 065 194.3 (Status: pending/in force, Query started: November 6, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2009 065 194.3
96EP file numberEAKZ19 20 7534.9
97EP publication numberEPN3628319
54Designation/titleTIBEHANDLUNG VON HEPATISCHER ENZEPHALOPATHIE UNTER VERWENDUNG VON RIFAXIMIN
51IPC main classICM
(ICMV)		 A61K 31/437 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 45/06 (2006.01), A61K 31/08 (2006.01), A61K 31/352 (2006.01), A61K 31/4164 (2006.01), A61K 31/426 (2006.01), A61K 31/4439 (2006.01), A61K 31/606 (2006.01), A61K 31/7016 (2006.01), A61K 31/785 (2006.01), A61K 38/14 (2006.01), A61K 38/31 (2006.01), A61P 1/16 (2006.01), A61K 31/395 (2006.01)
22DE application dateDATOct 2, 2009
96EP application dateEATOct 2, 2009
43Date of first publicationOTApr 1, 2020
Date of publication of grantPETFeb 14, 2024
71/73Applicant/ownerINHSalix Pharmaceuticals, Inc., Raleigh, NC, US
72InventorINFORBES, William, Raleigh, NC 27164, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
102349 P
Oct 2, 2008
Due dateFT
FG		Oct 31, 2026
Annual fee for the 18th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003628319A1
Searchable text: EP000003628319A1
Original document: EP000003628319B1
Searchable text: EP000003628319B1
43Date of first publicationEVTApr 1, 2020
Date of the first transfer into DPMAregisterEREGTApr 1, 2020
Date of the (most recent) update in DPMAregisterREGTOct 2, 2025
(Show all update days)(Hide all update days)
  • Oct 2, 2025
    • Due date: changed
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.02.2024: new
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.02.2024: deleted
  • Nov 29, 2024
    • Procedures: Opposition procedure, Opposition filed, 04.11.2024: changed
  • Nov 21, 2024
    • Procedures: Opposition procedure, Opposition filed, 04.11.2024: new
  • Sep 27, 2024
    • Due date: changed
  • Jul 24, 2024
    • St.36: changed (technical change)
  • Apr 27, 2024; Mar 23, 2024; Feb 15, 2024; Feb 8, 2024; Jan 30, 2024; Jan 25, 2024; Nov 23, 2023
    • Historical data not available for this/these date(s)
  • Apr 1, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Apr 1, 2020  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA May 14, 2020 May 14, 2020 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Feb 14, 2024  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Mar 7, 2024 Mar 7, 2024 Details anzeigen
5 New applicant/owner details New applicant/owner details Mar 22, 2024 May 2, 2024 Details anzeigen
6 Opposition procedure Opposition to patent filed Nov 4, 2024 Dec 24, 2024 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTApr 1, 2020
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 14, 2020
Issue numberHN20
YearPJ2020
Publication dateVTMay 14, 2020
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTFeb 14, 2024
Date of update of the procedureREGTOct 2, 2025
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMar 7, 2024
Issue numberHN10
YearPJ2024
Publication dateVTMar 7, 2024
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTFeb 15, 2024
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 22, 2024
Issue numberHN18
YearPJ2024
Publication dateVTMay 2, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSalix Pharmaceuticals, Inc., Raleigh, NC, US
71/73Previous applicant/ownerINHFSalix Pharmaceuticals, Ltd., Bridgewater, NJ, US
Date of update of the procedureREGTApr 27, 2024
View procedures Opposition procedure (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTNov 4, 2024
Issue numberHN52
YearPJ2024
Publication dateVTDec 24, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTNov 29, 2024